Trademark Attorney / Law Firm

William E. Sluss – Trademark Portfolio

William E. Sluss specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 3 total filings concentrated in this category. The practice also covers Class 29 (Meats & Processed Foods) along with 2 other Nice Classification classes. Filing activity spans from 2023 to 2024. Currently, 2 trademarks are registered and 1 is pending.

3 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

William E. Sluss's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

Frequently Asked Questions

How many trademark applications has William E. Sluss filed?

William E. Sluss has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered, 1 pending.

What trademark classes does William E. Sluss specialize in?

William E. Sluss has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has William E. Sluss been filing trademarks?

William E. Sluss's trademark filing history with the USPTO spans from 2023 to 2024, covering 1 year of trademark practice. During this period, William E. Sluss has handled 3 trademark applications.

What is William E. Sluss's trademark registration success rate?

William E. Sluss has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.